African American relapsed/refractory multiple myeloma patients have a progression free survival benefit with selinexor treatment in the STORM study
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
关键词
relapsed/refractory multiple myeloma patients,multiple myeloma,selinexor treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要